Yüklüyor......
Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report
RATIONALE: Fondaparinux, as a factor Xa-inhibitor, is used off label to manage heparin-induced thrombocytopenia (HIT), but little experience with HIT patients has been reported in the literature. Moreover, the use of fondaparinux for full anticoagulation in critically ill patients with HIT and renal...
Kaydedildi:
| Yayımlandı: | Medicine (Baltimore) |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Health
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6156017/ https://ncbi.nlm.nih.gov/pubmed/30212955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012236 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|